![]() |
|
|
-Reduced Neurosteroid Effects at GABAA Receptors
Departments of Psychiatry (S.M., Y.H., M.W., A.S., A.B., C.F.Z.), Molecular Biology and Pharmacology (X.J., A.S.E., D.F.C.), Anatomy and Neurobiology (S.M., C.F.Z.), and Anesthesiology (B.D.M., A.S.E.), Washington University School of Medicine, St. Louis, Missouri
Although neurosteroids have rapid effects on GABAA receptors, study of steroid actions at GABA receptors has been hampered by a lack of pharmacological antagonists. In this study, we report the synthesis and characterization of a steroid analog, (3
,5
)-17-phenylandrost-16-en-3-ol (17PA), that selectively antagonized neurosteroid potentiation of GABA responses. We examined 17PA using the
1
2
2 subunit combination expressed in Xenopus laevis oocytes. 17PA had little or no effect on baseline GABA responses but antagonized both the response augmentation and the direct gating of GABA receptors by 5
-reduced potentiating steroids. The effect was selective for 5
-reduced potentiating steroids; 5
-reduced potentiators were only weakly affected. Likewise, 17PA did not affect barbiturate and benzodiazepine potentiation. 17PA acted primarily by shifting the concentration response for steroid potentiation to the right, suggesting the possibility of a competitive component to the antagonism. 17PA also antagonized 5
-reduced steroid potentiation and gating in hippocampal neurons and inhibited anesthetic actions in X. laevis tadpoles. Analogous to benzodiazepine site antagonists, the development of neurosteroid antagonists may help clarify the role of GABA-potentiating neurosteroids in health and disease.
Address correspondence to: Dr. Steven Mennerick, Department of Psychiatry, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8134, St. Louis, MO 63110. E-mail: menneris{at}psychiatry.wustl.edu
This article has been cited by other articles:
![]() |
K. A. Grant, C. M. Helms, L. S. M. Rogers, and R. H. Purdy Neuroactive Steroid Stereospecificity of Ethanol-Like Discriminative Stimulus Effects in Monkeys J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 354 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, X. Jin, D. F. Covey, and J. H. Steinbach Neuroactive Steroids and Human Recombinant {rho}1 GABA Receptors J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 236 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System Endocr. Rev., June 1, 2007; 28(4): 387 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Akk, P. Li, B. D. Manion, A. S. Evers, and J. H. Steinbach Ethanol Modulates the Interaction of the Endogenous Neurosteroid Allopregnanolone with the {alpha}1beta2{gamma}2L GABAA Receptor Mol. Pharmacol., February 1, 2007; 71(2): 461 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. B. Saalmann, I. G. Morgan, and M. B. Calford Neurosteroids Involved in Regulating Inhibition in the Inferior Colliculus J Neurophysiol, December 1, 2006; 96(6): 3064 - 3073. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, D. F. Covey, J. H. Steinbach, and G. Akk Dual Potentiating and Inhibitory Actions of a Benz[e]indene Neurosteroid Analog on Recombinant {alpha}1beta2{gamma}2 GABAA Receptors Mol. Pharmacol., June 1, 2006; 69(6): 2015 - 2026. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Shannon, P. Porcu, R. H. Purdy, and K. A. Grant Characterization of the Discriminative Stimulus Effects of the Neuroactive Steroid Pregnanolone in DBA/2J and C57BL/6J Inbred Mice J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 675 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Shu, L. N. Eisenman, D. Jinadasa, D. F. Covey, C. F. Zorumski, and S. Mennerick Slow Actions of Neuroactive Steroids at GABAA Receptors J. Neurosci., July 28, 2004; 24(30): 6667 - 6675. [Abstract] [Full Text] [PDF] |
||||